A test that looks for tumor cells in the blood may make doctors better able to check whether chemotherapy is helping a prostate cancer patient, researchers reported on Tuesday. The CellSearch test, made by Johnson & Johnson (JNJ.N) unit Veridex, works better than standard tests for men whose prostate cancer has spread, the researchers said in the journal Lancet Oncology.